Toxicity of hyperthermic isolated limb perfusion with cisplatin for recurrent melanoma of the lower extremity after previous perfusion treatment
Open Access
- 15 August 1993
- Vol. 72 (4) , 1224-1229
- https://doi.org/10.1002/1097-0142(19930815)72:4<1224::aid-cncr2820720415>3.0.co;2-b
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremitiesWorld Journal of Surgery, 1992
- Isolated Limb Perfusion for Localized Melanoma of the ExtremityArchives of Surgery, 1990
- A Phase II Study of the Efficacy of Diamminedichloroplatinum (Cisplatin) for the Control of Locally Recurrent and Intransit Malignant Melanoma of the Extremities Using Tourniquet Outflow-Occlusion TechniquesAnnals of Surgery, 1989
- Results of isolated regional perfusion in the treatment of malignant soft tissue tumors of the extremitiesCancer, 1987
- The Pharmacokinetics of Cisplatin in Experimental Regional ChemotherapyCancer, 1987
- Toxicity and complications of vascular isolation and hyperthermic perfusion with lmidazole carboxamide (DTIC) in melanomaCancer, 1986
- Improved tissue perfusion during pressure regulated hyperthermic regional isolated perfusion. A clinical studyCancer, 1985
- Dosimetry of cytostatics in hyperthermic regional isolated perfusionCancer, 1985
- Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum ElectrodeNature, 1965
- Chemotherapy of CancerAnnals of Surgery, 1958